We Continue the Work of Those
Who Were the First.

  • Electrical Engineering
  • Light & Lighting
  • Power Engineering
  • Transportation
  • Automation
  • Communication
  • Smart Buildings
  • Industry
  • Innovation

Current issue

ELEKTRO 5/2018 was released on May 16th 2018. Its digital version will be available on June 6th 2018.

Topic: Lightning and overvoltage protection; EFS, EPS; ELO SYS 2018

Main Article
Energy router and its role in smart grids
Smart Cities (part 2 – volume 1)

SVĚTLO (Light) 2/2018 was released on March 16th 2018. Its digital version will be available immediately.

Fairs and exhibitions
Interior elite again after year in Letňany

Luminaires and luminous apparatuses
Emergency lighting
The future of industrial lighting has name INNOVA
GOLY luminaire – the practical high bay luminaire
McLED® – brand name of first rate quality LED lighting
VOLGA EU luminaire our choice for Europe

Hologram technology developed at UCLA

11.08.2017 | UCLA | newsroom.ucla.edu

A new system developed by UCLA researchers could make it easier and less expensive to diagnose chronic diseases, particularly in remote areas without expensive lab equipment.

The technology uses extremely simple optical hardware and a lens-free microscope, as well as sophisticated algorithms that help reconstruct the images of tissue samples. It could make much-needed diagnostic testing available and affordable for people in developing countries and remote areas that lack the expensive lab equipment currently used to perform tissue biopsies.

Hologram technology

The system for making biological samples transparent, also known as “tissue clearing,” and then imaging them using a lens-free microscope is described in an article published today in Science Advances, a journal of the American Association for the Advancement of Science. It was developed by a team led by Aydogan Ozcan, the UCLA Chancellor’s Professor of Electrical and Computer Engineering and Bioengineering and associate director of the California NanoSystems Institute; and Rajan Kulkarni, an assistant professor of medicine and dermatology at the David Geffen School of Medicine at UCLA, and a member of CNSI.

Read more at UCLA

Image Credit: Ozcan Research Group/UCLA

-jk-